Skinpendium gives non-dermatologist physicians a calibrated malignancy probability and the closest confirmed cases for every suspicious lesion — in seconds, inside the visit.
What it does
Transparent, calibrated and integrated. Skinpendium informs the biopsy-or-refer call; the clinician makes it.
A dual-head model on a frozen vision foundation model, trained on histopathology-confirmed dermoscopic images, scores malignancy and separates the common benign and malignant lesion classes.
Isotonic calibration keeps reported probabilities honest: a stated risk behaves like that risk, with no inflated confidence.
Every result arrives with the most visually similar histopathology-confirmed cases, so the reasoning is inspectable.
A SMART-on-FHIR plugin for Epic and Oracle Health (Cerner) writes DiagnosticReport, ServiceRequest, Task, Media back to the chart with server-side audit logging.
One shared clinical core: capture with quality gates, offline-first sync, per-patient galleries and PDF reports.
Images encrypted at rest, Safe Harbor de-identification, TLS everywhere and per-organization API keys with a full audit trail.
Validated performance
Melanoma sensitivity is the special control for this device category. Skinpendium is engineered to clear it while keeping specificity high enough to be useful in the room.
Trained and validated on biopsy-confirmed lesions, not clinician impressions.
Evaluated on images from clinics and sources the model never saw in training.
Every model change is registered before it is tested, and tested on its own, so an improvement is real rather than noise.
Workflow
Attach a dermoscope to your phone. On-device quality gates check focus, exposure and framing before anything is submitted.
The AI engine returns a calibrated malignancy probability, a differential and the closest confirmed cases in seconds.
Review the result beside your own assessment, then biopsy, refer or follow up. The report writes straight to the chart.
Provider workspace
Clinicians, devices and sites in one place, with every flagged lesion followed through to its pathology result.
Harborline Family Medicine
+18%
15% of captures
from 57 flagged
8 pending
Capture volume
12 weeks
Flag-to-pathology funnel
Last 30 days
Pathology results (33 returned)
Skinpendium is investigational, not FDA-cleared. Leave your email and we will tell you when it is available for clinical use.